Skip to main content
Full access
Ethics Commentary
Published Online: 15 January 2025

Ethical Considerations Related to Stigma in Mental Health Aspects of Treating Substance Use Disorders

Substance use disorders are among the most common, costly, and debilitating illnesses that affect the United States’ population. Each year, one in six Americans meet the criteria for these disorders (1). Nearly one in three Americans will qualify for a diagnosis of alcohol use disorder over the course of their lifetime (2). These diseases are estimated to cost the nation’s economy $400 billion through a combination of lost productivity, medical bills, accidents, and crime (3). Substance use disorders remain highly stigmatized in the United States and this stigma often prevents individuals from seeking treatment for their conditions (4). Even health care providers have consistently been found to demonstrate negative attitudes toward patients with substance use disorders (5). These negative attitudes are more likely to be directed at patients with substance use disorders than individuals with other psychiatric illnesses (6). Such biases may cause patients to experience lack of empowerment and endure poor treatment outcomes (5). Fortunately, a range of interventions—from educational programs to meaningful contact with individuals in recovery—have been demonstrated to reduce provider stigma and concomitantly improve care (7).
Patients with substance use disorders may eschew treatment for fear of judgment by their physicians, loved ones, or society. At the same time, concerns regarding the practical consequences of disclosing details of their substance use may also deter them from seeking appropriate care. For instance, patients may fear that disclosure to public authorities will cause them to lose their driving privileges, have their professional licenses suspended, or even negatively affect their parental rights. They may also worry that hospitals will disclose their substance use difficulties to family members, friends, or even employers. The duty to protect the confidences of patients with substance use disorders often comes into direct conflict with both mandatory and discretionary disclosure obligations, which creates complex ethical challenges for providers. Physicians must strive to offer patients appropriate reassurance while also following relevant laws, professional standards, and ethical norms.
One particular challenge for clinicians who treat patients with substance use disorders is how to respect the autonomy of these patients while preventing them from damaging their reputations and relationships as a result of their illnesses. Psychiatric advance directives offer a promising mechanism for patients with substance use disorders to specify their future wishes should their decision-making become impaired by substance use. The degree to which these documents are legally enforceable, as well as the ethics of enforcing them against patients with capacity, remains the subject of ongoing controversy.

Case 1, Part 1

Dr. C is a 55-year-old anesthesiologist who comes to your private outpatient psychiatric office at the behest of his wife for evaluation of worsening depression. At the outset of the evaluation, Dr. C expresses concerns regarding the confidentiality of his medical records. After you offer reassurance, he describes how he has been under considerable stress at work—after making a dosing error in the operating room several months earlier—and has been sleeping poorly. When you ask about substance use, Dr. C again expresses concerns about the confidentiality of his medical records.
1.1.
Which of the following choices offers legal protections for the confidentiality of medical records related to substance use disorders?
A.
Jaffee v Redmond and Powell v Texas
B.
Health Insurance Portability and Accountability Act of 1996 (HIPAA) and Emergency Medical Treatment & Labor Act of 1986 (EMTALA)
C.
HIPAA and Title 42 of the Code of Federal Regulations Part 2 (42 CFR Part 2)
D.
HIPAA and the Matthew Casey Wethington Act for Substance Abuse Intervention (Casey’s Law)
E.
Robinson v California and City of Grants Pass v Johnson
1.2.
Dr. C confesses that he is being sued in federal court because of the dosing error and fears that you will be compelled to testify against him at trial. You reassure him that such testimony is privileged as a result of which of the following U.S. Supreme Court rulings?
A.
Robinson v California
B.
Volk v DeMeerleer
C.
Branzburg v Hayes
D.
Trammel v United States
E.
Jaffee v Redmond

Case 1, Part 2

Once Dr. C is assured that you will not testify against him at his malpractice trial, he acknowledges that he has been drinking heavily (6–8 shots of hard liquor 2 to 3 nights per week), but only since the error in the operating room. He is adamant that he never consumes alcohol at work or during the days in which he is at the hospital, but only on weekends; the few times he has become inebriated during the week, he has notified work that he was ill. You believe him, but fear that his condition may deteriorate in the future and that he might eventually show up for duty intoxicated. Dr. C reports that his wife and children are unaware of the extent of his drinking and that he is adamantly opposed to telling them.
1.3.
Which of the following next steps is ethically and legally permissible?
A.
Warn Dr. C’s employer as is your duty per the principles outlined in Tarasoff v Regents of the University of California.
B.
Inform Dr. C that you must report his drinking to the state licensing authority for further investigation.
C.
Offer Dr. C voluntary admission to a rehabilitation and recovery facility, and if he is unwilling to agree to such treatment, pursue a court order for involuntary substance use treatment.
D.
Offer Dr. C a voluntary referral to a physician’s health program.
E.
Inform Dr. C that you will have to share this information with his wife per your state’s partner notification statute.
1.4.
The psychiatrist’s obligation to report physicians who practice while under the influence of alcohol reflects the ethical concept of:
A.
Boundary crossings
B.
Dual loyalty
C.
Justice
D.
Autonomy
E.
Strict liability

Case 2

Ms. X is a 28-year-old woman who presents to an outpatient psychiatrist, Dr. Y, with alcohol use disorder that is currently in remission and worsening anxiety in the setting of an ongoing divorce. She reports that she started drinking alcohol at age 12 and has had several periods of sobriety, but has also experienced relapses that have caused her to lose jobs and, in one instance, left her temporarily undomiciled. She now reports being sober for 8 months and wishes to engage in pharmacological treatment to reduce her ongoing cravings. She also wishes to execute a psychiatric advance directive to agree to involuntary treatment for her substance use disorder in the future should she relapse again.
2.1.
The type of psychiatric advance directive described previously is an example of which of the following?
A.
Ulysses contract
B.
Res ipsa loquitur
C.
Bargaining down
D.
Habeas corpus
E.
Unconscionability
2.2.
Several states have enacted versions of Casey’s Law, that is, statutes that allow family members to compel individuals to obtain substance use disorder treatment against their will. These statutes reflect the bioethical principle of which of the following?
A.
Justice
B.
Beneficence
C.
Informed consent
D.
Respect for persons
E.
Utility
2.3.
Dr. Y prescribes a combination of naltrexone and disulfiram to Ms. X and arranges for a follow-up appointment in 2 weeks. Ten days later, Dr. Y receives a subpoena related to Ms. X’s divorce case that requests a copy of her medical records and notes from the visit. What is the appropriate next step?
A.
Ignore the subpoena because Dr. Y does not have the legal authority to respond.
B.
Inform Ms. X of the subpoena and ask her whether she would like Dr. Y to release the documents.
C.
Comply with the subpoena because doing so is required by law.
D.
Provide copies of the medical record, but not Dr. Y’s psychotherapy notes.
E.
Do not contact Ms. X directly, because she is a party to the case, but hire an attorney to have the subpoena quashed.
2.4.
When Ms. X learns of the subpoena, she asks whether her medical records may be used against her in a future child custody hearing. Which of the following is true regarding medical records that document substance use disorders and child custody litigation?
A.
In state courts, substance use information in medical records is always privileged under Jaffee v Redmond.
B.
Judges in many states have considerable discretion regarding whether to consider such information in addressing child custody matters.
C.
Since substance use is a disease and not relevant to parental fitness, judges cannot rely upon information related to substance use when making custody determinations.
D.
The use of illicit substances may factor in child custody decisions, but the use of legal substances like alcohol will not be considered.
E.
Although psychiatric records may be subpoenaed, 42 CFR Part 2 prevents state courts from accessing medical records related to substance use disorders.

Answers

1.1.
The answer is C. Title II of HIPAA prevents most health care institutions (known as “covered entities”) from disclosing protected health information except under certain limited circumstances (8). 42 CFR Part 2 is a federal regulation that governs the confidentiality of substance use treatment records in certain federally funded programs (known as “Part 2” programs) (9). Both of these laws protect confidential medical records that are related to substance use disorders, although only HIPAA applies to the records of a patient who is seeing a provider in private practice such as Dr. C. Jaffee v Redmond (1996) is a U.S. Supreme Court decision that guarantees psychotherapist-patient privilege; Powell v Texas (1968) is a U.S. Supreme Court decision that permits the criminalization of public intoxication (choice A). Casey’s Law is a Kentucky statute, replicated elsewhere, that allows family members to petition for relatives with life-threatening substance use disorders to be involuntarily committed (10) (choice D). EMTALA is a federal law that requires hospitals to evaluate and stabilize all patients without regard to ability to pay (choice B). Robinson v California (1962) is a U.S. Supreme Court decision that prohibits states from criminalizing addiction; City of Grants Pass v Johnson (2024) is a U.S. Supreme Court decision that allows states to criminalize sleeping and camping outdoors (choice E).
1.2.
The answer is E. The U.S. Supreme Court decision in Jaffee v Redmond (1996) extended the psychotherapist-patient privilege to all federal courts. The privilege is said to be held by the patient, who has the right to prevent their psychotherapist from offering testimony regarding confidential disclosures (11). Trammel v United States (1980) is a U.S. Supreme Court decision that affirms spousal privilege (choice D). Branzburg v Hayes (1972) is a U.S. Supreme Court decision that rejects a similar privilege between journalists and sources (choice C). The U.S. Supreme Court decision in Robinson v California (1962) invalidated a California statute that criminalized the status of being addicted to narcotics (choice A). Volk v DeMeerleer (2016) is a Washington State court case that broadly expanded the duty to warn to all foreseeable victims of a psychiatric patient (choice B).
1.3.
The answer is D. Physicians’ health programs, sometimes known as professional assistance programs, are voluntary programs that offer support and monitoring to physicians who are struggling with substance use disorders, but have not harmed patients (12). Some programs expect a physician to temporarily surrender a license; others do not. Dr. C might be a candidate for such a program. Since Dr. C is not endangering patients at present, no grounds exist to breach confidentiality to either report him to the state licensing authority (choice B) or to warn his employer (choice A). Most states only permit treatment for substance use disorders on a voluntary basis, but those that do permit involuntary commitment do so in limited situations in which the substance use places the user in serious danger, which is not the case here (choice C). Partner notification statutes are mechanisms through which the sexual partners of individuals with certain infectious diseases, including HIV and syphilis, can be anonymously informed of their risk of exposure (13) (choice E); they may also be relevant to the exchange of needles by opioid users, but not to patients with alcohol use disorders.
1.4.
The answer is B. Dual loyalty refers to the simultaneous duty of physicians to serve the interests of their patients and society at large (14). The concept of dual loyalty emerged in the early 20th century in relation to public health and safety concerns. Boundary crossings are acts by a provider that transcend the normal professional roles of physicians (choice A). The ethical principle of autonomy refers to the right of the patient to make their own decisions and control their own care (choice D). The ethical principle of justice requires that similar individuals be treated similarly and emphasizes the importance of equity in the delivery of medical services (choice C). Strict liability is a standard in both civil and criminal law that judges an act independent of the intention behind that act or the fault of the perpetrator (choice E) (15).
2.1.
The answer is A. A Ulysses contract or Ulysses pact is a document that allows individuals “to commit themselves now to a particular course of treatment at a future time if they suspect they will not be willing or able to follow that course of treatment at that future time” (16). These documents take their name from an episode in Homer’s Odyssey. Res ipsa loquitur is a legal concept under which negligence can be automatically inferred from certain actions (choice B). Bargaining down is a phenomenon in which patients state prior to becoming ill or disabled that they would never wish to live in a particular condition, but once they find themselves in that condition, they decide they do wish to live (choice C). Habeas corpus, a Latin term meaning to have the body, is a concept in criminal law used to challenge unlawful detentions (choice D). Unconscionability is a concept in contract law that prevents the enforcement of contractual agreements that defy modern social norms or public policies (17) (choice E).
2.2.
The answer is B. Beneficence, one of the four principles of medical ethics proposed by Thomas Beauchamp and James Childress, is the duty that physicians must serve the well-being of their patients. It is often considered a corollary to the principle of nonmalfeasance (“do no harm”) (18). Justice is another concept in medical ethics that requires each individual to be treated fairly and equitably (choice B). Informed consent is a requirement in both clinical care and human subject research that patients receive a reasonable disclosure of relevant information prior to any intervention and then offer voluntary agreement to proceed (choice C). Respect for persons is a concept proposed by the Belmont Report (1979) that includes both upholding patient autonomy and protecting individuals with diminished autonomy (choice D). Utility is a philosophical principle that seeks to achieve the most widespread positive outcomes for the largest number of individuals (choice E).
2.3.
The answer is B. The next appropriate step for Dr. Y is to discuss the subpoena with Ms. X and ask whether she wishes to comply with the subpoena. Dr. Y may also wish to consult an attorney at this juncture. Different types of subpoenas exist and Dr. Y may have legitimate grounds, such as physician-patient or psychotherapist-patient privilege, not to provide the medical records. Complying without Ms. X’s consent before raising these issues with the court runs the risk of a lawsuit for breach of confidentiality (choice C). Although HIPAA distinguishes between medical records and psychotherapy notes, it does not mean that medical records should automatically be released (choice D). Quashing the subpoena may be the ultimate aim, but privilege is held by the patient and Ms. X should be involved in the decision regarding how to proceed (E). A subpoena should never be ignored because it is a legal summons and disregarding it can result in serious legal consequences for the physician (choice A) (19).
2.4.
The answer is B. Judges in most states have broad latitude regarding what evidence to consider in rendering determinations of child custody. Since active substance use may raise questions that are related to parental fitness, judges may choose to subpoena such records. Substance use disorders are diseases, but as with other serious medical conditions, that does not mean they cannot be used in child custody hearings (choice C). Whether the substances used are legal or illegal is not likely to be a relevant factor in such decisions (choice D). 42 CFR Part 2 shields only substance use treatment records in certain federal centers (i.e., “Part 2” programs) and not more broadly (choice E). Some form of psychotherapist-patient privilege does exist in all 50 states; however, no privilege is absolute, and exceptions do exist in certain areas in which the mental well-being of the party is at stake; child custody cases are often among these exceptions to the general principle of psychotherapist-patient privilege (choice A) (20).

References

1.
National Survey on Drug Use and Health. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2023. https://www.samhsa.gov/data/report/2022-nsduh-detailed-tables
2.
Ignaszewski MJ: The epidemiology of drug abuse. J Clin Pharmacol 2021; 61:S10–S17
3.
2022 National Healthcare Quality and Disparities Report. Bethesda, MD, National Institutes of Health, Agency for Healthcare Research and Quality, 2022. https://www.ncbi.nlm.nih.gov/books/NBK587176/
4.
Adams JM, Volkow ND: Ethical imperatives to overcome stigma against people with substance use disorders. AMA J Ethics 2020; 22:E702–E708
5.
Zwick J, Appleseth H, Arndt S: Stigma: how it affects the substance use disorder patient. Subst Abuse Treat Prev Policy 2020; 15:50
6.
van Boekel LC, Brouwers EP, van Weeghel J, et al: Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend 2013; 131:23–35
7.
Bielenberg J, Swisher G, Lembke A, et al: A systematic review of stigma interventions for providers who treat patients with substance use disorders. J Subst Abuse Treat 2021; 131:108486
8.
Rovner JA: Health law: analysis of the provisions of the Health Insurance Portability and Accountability Act of 1996. ABA J 1998; 2:1; 38–39. https://www.jstor.org/stable/23781834
9.
Rackish M: Revamping part 2: an analysis of revisions to the federal substance use disorder treatment confidentiality regulations. J Health Care Law Policy 2023; 26:215. https://digitalcommons.law.umaryland.edu/jhclp/vol26/iss2/3
10.
Appel JM: Financial equity in involuntary treatment for substance use disorders. J Am Acad Psychiatry Law 2023; 51:357–366
11.
Aronson RH: The mental health provider privilege in the wake of Jaffe v. Redmond. Okla Law Rev 2001; 54:591. https://digitalcommons.law.ou.edu/olr/vol54/iss3/7
12.
DuPont RL, McLellan AT, White WL, et al: Setting the standard for recovery: physicians’ health programs. J Subst Abuse Treat 2009; 36:159–171
13.
Lichtenstein B, Whetten K, Rubenstein C: “Notify your partners—it’s the law”: HIV providers and mandatory disclosure. J Int Assoc Provid AIDS Care 2014; 13:372–378
14.
Shestack JJ: Psychiatry and the dilemmas of dual loyalties. ABA J 1974; 60:1521. https://heinonline.org/HOL/LandingPage?handle=hein.journals/abaj60&div=263&id=&page=
15.
Burstein CH: Medical malpractice: a move toward strict liability. Loyola Law Rev 1975; 21:194–217
16.
Spellecy R: Reviving Ulysses contracts. Kennedy Inst Ethics J 2003; 13:373–392
17.
Waddams SM: Unconscionability in contracts. Mod Law Rev 1976; 39:369–393. https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1468-2230.1976.tb01462.x
18.
Jansen LA: Medical beneficence, nonmaleficence, and patients’ well-being. J Clin Ethics 2022; 33:23–28
19.
Mossman D: “You’ve been served”: what to do if you receive a subpoena. Curr Psychiatry 2015; 14:33–37. https://www.mdedge.com/psychiatry/article/104566/practice-management/youve-been-served-what-do-if-you-receive-subpoena?sso=true
20.
Waits C: Comment: the use of mental health records in child custody proceedings. J Am Acad Matrim Law 2001; 17:159. https://aaml.org/wp-content/uploads/the_use_of_mental_health-comments-17-1.pdf

Information & Authors

Information

Published In

History

Published in print: Winter 2025
Published online: 15 January 2025

Keywords

  1. Treatment Issues
  2. Confidentiality
  3. Sociopolitical Issues
  4. Stigma/Discrimination

Authors

Details

Jacob M. Appel, M.D., J.D. [email protected]
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York.

Notes

Send correspondence to Dr. Appel ([email protected]).

Competing Interests

Dr. Appel reports no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Figures

Tables

Media

Share

Share

Share article link

Share